VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance

Researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers.

Go to Source

(Visited 1 times, 1 visits today)

Site Footer

Sliding Sidebar